SensiQ Technologies, Inc. develops and manufactures innovative tools for the advancement of life sciences research. SensiQ Technologies offers a suite of instruments and platforms for biomolecular interaction analysis using Label-Free Surface Plasmon Resonance (SPR) technologies. The technologies are based on a family of patents licensed from Sensata Technologies Inc. SensiQ Technologies, Inc. also offers contract services for fragment screening, antibody screening, and assay development. Additional information is available on the company's website at: www.sensiqtech.com.